AN2 Therapeutics Inc
Biotechnology
Healthcare
ANTX
30.05 M shares
NASDAQ US
traded
22 Sep 2025
listed
no
open
1.33
52 week high
20.99
high
1.35
52 week low
0.00
previous Close
1.32
P/E ratio
market cap
31.68 M
div yield
0
net incoming
-6.46 M
39.32 %
net profit margin
-646200000.00 %
0.00 %
operating incoming
-7.22 M
37.45 %
net change in cash
-1.77 M
-29.21 %
cash on hand
18.22 M
-8.83 %
top